Global Track and Trace Solutions Market Size by Product, Technology, Application, and End-User – Segment-Level Market Assessment, Growth Opportunity Analysis, Competitive Landscape & Forecast to 2034
Overview
Track and Trace Solutions Market was valued at USD 6.52 Billion in 2025, and is expected to reach USD 18.52 Billion by 2034, exhibiting a CAGR of 12.3% during the forecast period (2026-2034).
Healthcare businesses and organisations can better control their supply chains and lower the risks of obtaining fake pharmaceuticals with the help of track and trace (TandT) systems. It is the process for finding out a drug's current and previous locations. Benefits including ongoing transparency, packaging and logistics management, and services for product ID verification, which make it easy for products to flow through the distribution chain, are a key growth driver for track and trace solutions market.
Track and Trace Solutions Market Size, Growth & Share Analysis
To know about the Research Methodology :- Request Free Sample Report
The global increase in healthcare product theft and counterfeiting is largely responsible for the market's growth. Manufacturers of medical devices, pharmaceuticals, cosmetics, and biopharmaceuticals are implementing track and trace strategies to safeguard their goods and reputations. The deployment of track and trace solutions in the healthcare sector is also expected to be driven by favourable regulations for the implementation of standardization.
Track and Trace Solutions Market Dynamics
Thanks to the increasing deployment of track and trace systems by pharmaceutical and medical device businesses, the track and trace solutions market is expected to experience significant growth. Companies in the pharmaceutical and biopharmaceutical industries struggle with drug counterfeiting. Therefore, companies are adopting track and trace technologies for supply chain management. It has been discovered that low- to middle-income nations like India and Africa are more likely to see an invasion of substandard/counterfeit medicines. A 2019 report from the United States Trade Representative (USTR) estimates that 20% of all medications sold in India were counterfeit.
Theft and product counterfeiting are the main issues that pharmaceutical, biopharmaceutical, and cosmetic firms deal with. The WHO estimates that approximately 10% of all medications worldwide are fake, with this number being substantially higher in several African, Asian, and Latin American nations (10% to 30%). Each year, the use of fraudulent medications claims hundreds of lives. To protect consumers against fraudulent medications and other items, the governments of several nations have established standards and rules requiring the use of track and trace solutions in the healthcare sector. As a result, these factors are driving the growth of the track and trace solutions market.
Track and trace adoption in the supply chain is also driven by advances in products and technology like RFID. By the end of 2023, it is expected that more than 40 nations and more than 75% of the global supply of medicines will be subject to track and trace legislation. The expensive cost of implementing track and trace in the supply chain, however, might limit this track and trace solutions market's growth. In addition, the industry is expected to be driven by strict laws and norms pertaining to the implementation and aggregation of serialization. Therapeutic Goods Administration (TGA) updated its product coding criteria in July 2019 in an effort to lessen counterfeiting in Australia.
However, the high implementation costs associated with track and trace and the absence of globally agreed-upon standards for serialization and aggregation are expected to limit track and trace solutions market growth through the forecast period.
A Blockchain-Based Track and Trace Solution Helps India's Pharmaceutical Industry:
Traceability and supply chain security are big concerns for the Indian pharmaceutical business. Every step of the drug manufacturing process, from locating high-quality raw materials to maintaining the cold chain integrity to safety alerts and drug recalls, is a source of worry in the Indian environment. On the other hand fake medications undermine the pharmaceutical manufacturing industry and put unknowing people in danger. According to MMR report study counterfeit drugs occupy a staggering 29 percent of the local medicine market of India in the year 2023. The increasing use of blockchain-based track and trace solution in pharmaceutical industry is driving the track and trace solutions market growth in India.
The business has attempted to address worries regarding track and traceability for drug pharmaceutical counterfeiting over global positioning system (GPS), RFID (Radio-Frequency Identification) tags, electronic data interchange (EDI), barcodes and QR codes, near-field communication (NFC) and other technologies.
A blockchain node that represents the pharmaceutical supply chain can be identified; this node will be governed by a regulatory authority at the federal level. Every stakeholder and party participating in the drug supply chain will enter their information into the node. For each batch and unit produced, the pharmaceutical manufacturing company, for instance, records the production information and time. When the batch is placed onto the trucks, the loading docks will record it. The temperature sensors that are installed in the trucks will keep track of the current weather conditions, etc.
The Pharmaceutical Track and Trace Regulations:
| Market Regulations | Description |
| Drug Supply Chain Security Act (DSCSA) | The United States passed the Drug Supply Chain Security Act (DSCSA) in November 2013 so as to prevent drug counterfeiting. The second section of the act is a federal framework that addresses the safety of the supply chain. It is expected to be completed in 2023 to cover the entire pharmaceutical industry. In the implementation used by the USA, there is no authority where traceability data is stored. That is why all stakeholders have to keep track of the products they own. For the pharma track and trace system that is tried to be implemented in the United States, it can be interpreted as “independent from the authority and managed by the industry” when compared to European and other countries. In short, the pharmaceutical track and trace system used in America operates with a little more self-control logic |
| Chestny Znak | Russia uses Chestny Znak tracking system for the traceability of various product groups like tobacco, fur & shoes, including medicines. Registrations to the system started in 2019 for high-cost medications, & as of July 1, 2020, it has become mandatory for all medications. Unlike the US pharmaceutical track & trace system, the Russian’s system is a central one. Manufacturers, customs, importers, wholesalers, marketers, pharmacies, and patients are the actors of the supply chain. While CRPT is the institution responsible for serialization in Russia, MDLP supervises the circulation of pharmaceuticals and OMS supervises the generation of serial numbers and 2D codes. By applying the 2D code, which includes the global trade item number (GTIN), serial number, crypto key and crypto code, each product becomes singularized. The pharmaceutical track and trace solutions which are used by companies should also be able to apply these standards. Russia applies a crypto key and crypto code, as well as applying the information required by US and European regulations to the product packaging (GTIN and serial number). Thus, it can identify more data to the product in the pharmaceutical track and trace system in a more secure way. |
Track and Trace Solutions Market Segment Analysis:
Due to its increasing usage in healthcare organisations, including pharmaceutical, biopharmaceutical, and medical device firms, software solutions held the greatest revenue share of the track and trace solutions market over 50.76 percent in the year 2025. These software programmes are used to track cases and bundles, manage product lines, warehouse inventory, and ship orders continuously. Such software companies are spending money on RandD to improve product development, which is expected to spur growth. The track and trace solutions market's software solutions category is expected to be the most profitable one. Software businesses are investing more in RandD and putting more emphasis on customer service, which is helping this market segment growth. Over the forecast period, the hardware systems segment is expected to have profitable growth.
The printing and marking solutions segment had the maximum sales share in the hardware systems section in the year 2025. To guarantee the quality and authenticity of the products, this system is crucial to the production and supply chain. The requirement to achieve regulatory compliance and growing demand for serialisation are driving track and trace solutions market growth. In order to comply with the requirements of the Drug Supply Chain Security Act (DSCSA) by 2025, printing and marking technology is expected to be essential. The development of coding technologies like laser marking systems, large character marking (LCM), and thermal transfer overprinting (TTO) is also anticipated to drive track and trace solutions market growth during the forecast period.
Due to the regulatory bodies' increased focus on the implementation of the same, serialisation solutions held the maximum revenue share of over 55.0% in the year 2025. The healthcare sector, national governments, and local governments are all taking action to reduce product theft and medicine fraud. In order to comply with the new ePedigree standards, which are necessary for product traceability across the supply chain, serialisation is a crucial step.
Additionally, manufacturers' enhanced attention to patient safety and brand protection is expected to fuel segment growth during the forecast period. The increased complexity and diversity of serialisation standards, particularly in the pharmaceutical business, provide difficulties for manufacturers. Manufacturers find it challenging to adopt serialisation in track and trace due to differences in standards and legislation between nations and the administration of aggregated complicated data. However, the adoption of serialisation in the supply chain is driven by the rising rate of pharmaceutical and other healthcare product fraud. Because healthcare organisations are increasingly adopting these solutions, the track and trace solutions market is expected to expand rapidly throughout the forecast period.
In the year 2025, barcode technology had the highest revenue share more than 80.0%. The 2D barcode is now the most widely used type of barcode and is expected to remain so for the whole forecast period. The increased revenue share is mostly due to the expanding use of 2D barcodes in the packaging of pharmaceutical and biopharmaceutical products. The demand for 2D barcode-based solutions is also increased by the substantial data store capacity of 2D barcodes compared to linear barcodes and their greater industry acceptance.
The introduction of barcode technology in the healthcare sector was prompted by governmental rules and a rise in the sales of counterfeit drugs. In the year 2011, the Directorate General of Foreign Trade, for instance, published a notification announcing the implementation of a track and trace system with barcode technology for pharmaceutical products shipped from India. As a result, the track and trace solutions market has seen a growth in demand for barcode technology, which is expected to continue during the forecast period. The RFID segment is expected to develop at the fastest rate. Technology advantages including great durability and reusability, higher data storage capacity, and no need for line of sight are important elements boosting the segment's growth.
In the year 2025, pharmaceutical firms held the track and trace solutions market with a revenue share of nearly 25.0%. A critical step in addressing the issues facing pharmaceutical firms is the use of serialisation, which ensures secure product track and trace capabilities across diverse entities across the supply chain. Currently, track and trace solutions are required by federal and state requirements for pharmaceutical firms, which is driving up demand. The Senate adopted H.R. 3204, the Drug Quality and Security Act, becoming U.S. federal law in September 2013. This measure mandates that manufacturers include a product identifier number on every prescription medicine package and case they produce. In 2025, there was a significant need for track and trace solutions for the pharmaceutical and biopharmaceutical supply chain, and it is expected that this demand will continue to grow throughout the forecast period.
Track and Trace Solutions Regional Insights:
Due to its advanced healthcare infrastructure and strictly regulated serialisation and aggregation norms, North America had the maximum revenue share of over 35.0% in the year 2025. The FDA advises pharmaceutical and other healthcare industries to use automatic identification technology such as barcoding and RFID. Additionally, the track and trace solutions market is expected to be driven by the U.S.'s adoption of this technology and its highly established healthcare infrastructure.
In terms of revenue, Europe has overtaken Asia as the second-largest regional market for track and trace solutions, and this trend is expected to continue through 2034. This can be due to the region's proximity to developed economies like Germany, Turkey, the United Kingdom, France, and Italy. To combat prescription fraud and theft, the European Union wants to gradually integrate track and trace technologies throughout the healthcare supply chain. The Falsified Medicines Directive prohibits companies from marketing their goods in Europe if they do not adhere to the rules on drug serialisation.
Track and Trace Solutions Market Recent Development
| Date | Company | Development | Impact |
|---|---|---|---|
| 27 November 2025 | U.S. Food and Drug Administration (FDA) | The FDA officially concluded its final stabilization period for the Drug Supply Chain Security Act (DSCSA), enforcing full electronic interoperable tracing requirements. | This mandate forces all pharmaceutical supply chain partners to maintain 100% digital unit-level traceability, significantly reducing counterfeit risks. |
| 01 February 2025 | Directorate General of Foreign Trade (DGFT), India | India implemented a new export serialization mandate, requiring QR-code-based tracking for all pharmaceutical drug exports. | The policy enhances cross-border supply chain visibility and aligns Indian manufacturers with global anti-counterfeiting standards. |
| 10 March 2026 | TraceLink Inc. | The company launched an AI-driven supply chain control tower integrated with its core serialization platform. | The solution provides predictive disruption analysis, allowing manufacturers to mitigate risks before they impact product availability. |
| 20 May 2026 | Antares Vision S.p.A. | The firm introduced a new cloud-native serialization software module designed specifically for small and medium-sized enterprises (SMEs). | This reduces the high cost of entry for smaller manufacturers, accelerating market-wide adoption of track and trace technologies. |
Track and Trace Solutions Market Scope: Inquiry Before Buying
| Global Track and Trace Solutions Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | US $ 6.52 Bn. |
| Forecast Period 2026 to 2034 CAGR: | 12.3% | Market Size in 2034: | US $ 18.52 Bn. |
| Segments Covered: | by Product | Software Hardware Components Standalone Platforms |
|
| by Technology | RFID 2D Barcodes Linear Barcodes |
||
| by Application | Serialization Aggregation Tracking, Tracing, and Reporting |
||
| by End-User | Pharmaceutical and Biopharmaceutical Companies Food Industry Medical Device Companies Cosmetic Industry Other End Users |
||
Track and Trace Solutions Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina, Columbia and Rest of South America)
Key Players are:
1. Zebra Technologies Corporation (US)
2. Xyntek(US)
3. Systech(US)
4. SAP Se (US)
5. RFXCEL.CORP. (US)
6. METTLER TOLEDO (US)
7. PharmaSecure Inc. (US)
8. Tracelink (US)
9. Optel Group (Canada)
10.Axway (France)
11.Siemens(Germany)
12.Uhlmann (Germany)
13.Körber Medipak Systems(Germany)
14.WIPOTEC-OCS GmbH.(Germany)
15.Robert Bosch GmbH (Germany)
16.Laetus GmbH (Germany)
17.syntegon (Germany)
18.Sea Vision(Italy)
19.Antares Vision (Italy)
20.Adents (Ireland)
21.ACG Worldwide (India)
22.Jekson Vision (India)
Frequently Asked Questions:
1] What is the growth rate of the Global Track and Trace Solutions Market?
Ans. The Global Track and Trace Solutions Market is growing at a significant rate of 12.3% during the forecast period.
2] Which region is expected to have the highest growth rate in the Global Track and Trace Solutions Market?
Ans. The North America region is expected to hold the highest growth rate in the Track and Trace Solutions Market during the forecast period.
3] What is the market size of the Global Track and Trace Solutions Market by 2034?
Ans. The market size of the Track and Trace Solutions Market by 2034 is expected to reach USD 18.52 Bn.
4] What are the major key players of the Global Track and Trace Solutions Market?
Ans. The major key players of the Global Track and Trace Solutions Market are Zebra Technologies, Xyntek, Systech, Siemens, Körber Medipak Systems, Sea Vision, Adents, ACG Worldwide, Tracelink, Optel Group, METTLER TOLEDO, Axway, Antares Vision, Uhlmann
Jekson Vision, RFXCEL.CORP. Laetus GmbH, Grant-Soft Ltd. PharmaSecure Inc. WIPOTEC-OCS GmbH.
5] What factors are driving the growth of the Global Track and Trace Solutions Market in 2025?
Ans. The increased deployment of track and trace solutions by pharmaceutical and medical device firms is the major factor expected to drive the global track and trace solutions market during the forecast period.